You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +44 (0)20 7769 6707 or email: apus@templetonapus.com |
|
Most viewed
- 1. Ionis and UCSD take an antisense approach to fighting treatment-resistant multiple myeloma
- 2. TRIGR Therapeutics and Elpiscience Biopharmaceuticals Announce $117 Million Exclusive China Licensing Transaction for TR009, a Phase 1B Dual Angiogenic Bispecific Antibody Targeting DLL4/VEGF
- 3. COVID Vaccines: Ask The Experts
- 4. A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated
- 5. 2021 Biotech IPOs Get Off to a Roaring Start
- 6. Merck, Bayer win FDA approval for heart failure drug
- 7. MyID Launches Partnership with Merck
- 8. Robert Embree and Jason Allchin Team Up to Start EmeritusDX
- 9. NEUVOGEN Announces Participation at B. Riley Virtual Oncology Investor Conference
- 10. We Dare You Not To Smile as Survivors Ring Bells Celebrating End of Cancer Journeys in Uplifting TikTok Videos
Last updated at 11:05 GMT
Hot News Makers
Health/Pharma Companies
-
61265.82
-
23406.93
-
14865.21
-
12917.67
-
12643.28
-
11069.62
-
10415.03
-
9878.87
-
9188.43
-
8039.82
Last updated at 10:10 GMT
© Copyright 2021 Templeton Apus. All rights reserved.
Made with 
and
in the EU & the UK
and
in the EU & the UK